Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GRAVITI StudyAilsa Hart, Remo Panaccione, Flávio Steinwurz et al.|Gastroenterology|2025Cited by 46